Literature DB >> 8533558

Death rates from ischemic heart disease in women with a history of hypertension in pregnancy.

L S Jónsdóttir1, R Arngrímsson, R T Geirsson, H Sigvaldason, N Sigfússon.   

Abstract

BACKGROUND: Evidence about the influence of hypertension in pregnancy on later health and in particular the risk of cardiovascular disorders is conflicting, although a link has been suggested. In a population-based study with a long follow-up time the potential association between hypertension in pregnancy, preeclampsia and eclampsia with increased death rates from ischemic heart disease (IHD) was investigated.
METHODS: All 7543 case records at the main maternity hospital in Iceland during 1931-1947 were reviewed to identify women with hypertension in pregnancy, subdivided by parity and severity of disease into those with eclampsia, preeclampsia and hypertension alone. Information on those who had died was obtained from death certificates, supplemented by autopsy reports and hospital records. Death rates from IHD were compared to population data from public health and census reports during corresponding periods and between study groups.
RESULTS: Of 374 hypertensive women 177 had died. The death rate was slightly higher among women with any hypertension in pregnancy than in the reference population (RR = 1.20; 95% CI 1.01-1.42). About half of the increase was attributed to excess mortality from IHD with a relative risk of dying of 1.47 (95% CI 1.05-2.02). The relative risk of dying from IHD was significantly higher among eclamptic women (RR = 2.61; 95% CI 1.11-6.12) and those with preeclampsia (RR = 1.90; 95% CI 1.02-3.52) than those with hypertension alone. Parous women at the index pregnancy had a twofold higher risk of dying from IHD than primigravid women (RR = 2.05; 95% CI 1.19-3.55; p = 0.01).
CONCLUSION: There is an indication of increased death rates among women with a history of hypertension in pregnancy, where ischemic heart disease may be more common than in the general population.

Entities:  

Mesh:

Year:  1995        PMID: 8533558     DOI: 10.3109/00016349509021195

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  60 in total

1.  Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families.

Authors:  Hannele Laivuori; Päivi Lahermo; Vesa Ollikainen; Elisabeth Widen; Leena Häivä-Mällinen; Helena Sundström; Tarja Laitinen; Risto Kaaja; Olavi Ylikorkala; Juha Kere
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

Review 2.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

Review 3.  Management of hypertension before, during, and after pregnancy.

Authors:  P Rachael James; Catherine Nelson-Piercy
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

4.  Hypertension in pregnancy is associated with elevated C-reactive protein levels later in life.

Authors:  Catherine M Brown; Stephen T Turner; Kent R Bailey; Thomas H Mosley; Sharon L R Kardia; Heather J Wiste; Iftikhar J Kullo; Vesna D Garovic
Journal:  J Hypertens       Date:  2013-11       Impact factor: 4.844

5.  The relationship of a family history for hypertension, myocardial infarction, or stroke with cardiovascular physiology in young women.

Authors:  Carole A McBride; Sarah A Hale; Meenakumari Subramanian; Gary J Badger; Ira M Bernstein
Journal:  Reprod Sci       Date:  2013-09-10       Impact factor: 3.060

Review 6.  Leisure time physical activity and the risk of pre-eclampsia: a systematic review.

Authors:  H T Wolf; K M Owe; M Juhl; H K Hegaard
Journal:  Matern Child Health J       Date:  2014-05

7.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

Review 8.  Drug treatment of hypertension in pregnancy.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

9.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

10.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.